Internal Medicine/Gastroenterology


Devang N. Prajapati, MD

Associate Clinical Professor of Medicine, UCSF









  Medical School:

University of Toronto

Toronto, Canada

  Residency: University of Toronto
  Fellowship: Gastroenterology / Hepatology, Medical College of Wisconsin Milwaukee
  Board Certified:

Internal Medicine


  Awards and Recognition:

2002 Trainee Research Award, Population Science, Medical College of Wisconsin Cancer Center
2004 Nominated for “Healing Hands” Award, Veterans Affairs, Central California Healthcare System
2005 Certificate of Recognition, Veterans Affairs, Central California Healthcare System



  1. James LR, Lajoie G, Prajapati D., Gan BS., Bargman JM., Calciphylaxis precipitated by ultraviolet light in a patient with end stage renal disease secondary to system lupus erythematosus. American Journal of Kidney Diseases. 1999 Nov:34(5):932-6. PubMed PMID: 10561152.
  1. Prajapati, DN, Newcomer J, Emmons, J, Abu-Hajir,M, Binion, DG. Case Report: Successful Treatment of an Acute Flare of Crohn’s Colitis During Pregnancy with Unfractionated Heparin After Inadequate Response to Corticosteroids. Inflamm Bowel Dis 2002 May;8(3):192-5. PubMed PMID: 11979140.
  1. Kugathasan S, Levy MB, Saeian K, Vasilopoulos S, Kim JP, Prajapati D, Emmons J, Martinez A, Kelly KJ, Binion DG. Infliximab re-treatment in Crohn’s disease adults and children: Risk Factors of the Development of delayed severe systemic reaction.  Am J Gastroenterol. 2002 Jun 97(6):1408-14. PubMed PMID: 12094858.
  1. Prajapati DN, Kim JP, Spinelli KS, Sudakoff G, Stewart ET, Komorowski RA, Telford GL, Binion DG. Case Report: “Popcorn” dystrophic ileal calcification in a patient with Crohn’s disease. Inflamm Bowel Dis. 2003 Jan;9(1):25-7. PubMed PMID: 12656134.
  1. Prajapati DN, Saeian K, Kim JP, Binion DG et al. Volume and Yield of Screening Colonoscopy at a Tertiary Medical Center after change in Medicare Reimbursement. Am J Gastroenterol. 2003 Jan;98(1):194-9. PubMed PMID: 12526957.
  1. Prajapati DN, Hogan WJ. Sphincter of Oddi Dysfunction and Other Functional Biliary Disorders: Evaluation and Treatment. Gastroenterology Clinics of North America 2003 June; 32(2)601-18.
  1. Prajapati DN, Knox JF, Emmons J, Saeian K, Csuka ME, Binion DG. Leflunomide of Crohn's Disease Patients Intolerant to Standard Immunomodulator Therapy. J Clin Gastroenterol. 2003 Aug;37(2):125-8. PubMed PMID: 12869881.



Hepatitis C – Beginning stages of the project.


Book Chapters


  1. Prajapati DN, Hogan WJ. “Anorectal Manometry”. In: Colonic Diseases. Edited by Timothy R. Koch, MD p 297-319.  Totowa, New Jersey: Humana Press, 2003.
  2. Prajapati DN, Shaker R. “Dysphagia”. In: Encyclopedia of Gastroenterology.  Edited by Leonard R. Johnson, MD. p 656 659. Boston: Academic Press 2004.
  3. Prajapati DN, Shaker R. “Swallowing”. In: Encyclopedia of Gastroenterology.  Edited by Leonard R. Johnson, MD. p 480 484,Boston: Academic Press 2004.
  4. Prajapati DN, Shaker R.” Recent Concepts and Advances in the Study of  GERD: Epidemiology, Pharyngeal pHmetry and Transnasal Esophagogastroduodenoscopy” In Multidisciplinary Focus of the Esophageal Pathology and its Complications, Edited by Manuel Rodriguez-Tellez. p 215 – 232. Madrid:International Marketing & Communication S.R., 2006.





  1. Prajapati DN, Emmons J, Kim JP, Binion DG. Successful use of leflunomide in Crohn’s disease patients with azathioprine intolerance. American College of Gastroenterology 2001:P510.
  2. Prajapati DN, Hogan WJ, Massey BT. Ileitis presenting years following total proctocolectomy for ulcerative colitis. American College of  Gastroenterology 2001: P666.
  3. Prajapati DN, Otterson MF, Kim JP, Eammons J, Binion DG. Post-operative use of infliximab in high-risk Crohn’s disease(CD) patients following multiple stricturoplasties. Am J Gastroenterol 2001;96(9):A965.
  4. Gawrieh S, Prajapati DN, Saeian K et al. Prevalence and patterns of liver function test abnormalities in patients with inflammatory bowel disease. Hepatology 2002;36(4) Pt 2 of 2:334A.
  5. Kugathasan S, Prajapati DN, Kim JP, et al. Infliximab Outcome in Children and Adults with ulcerative colitis. Gastroenterology 2002; 122(4) Supplement:A615.
  6. Attila T, Saiean K, Kounev V, Levy MB, Knox JF, Emmons JE, Prajapati DN, Kugathasan S, Binion DG. Episodic Infusion Schedule and Azathioprine Intolerance Correlate with The Development of Severe Adverse Reaction During Infliximab Retreatment for Crohn’s Disease. Gastroenterology 2002;122(4) Supplement A526.
  7. Attila T, Prajapati DN, Otterson MF, Binion DG. Azathioprine Associated Pulmonary Nodules in a Patient with Crohn’s Disease. Am J Gastreoenterol 2002;97;(9);S226.
  8. Bal JS, Wong H, Prajapati DN. Development of Lichen Planus During Pegylated Interferon Alfa-2B and Ribavirin Therapy for Hepatitis C. Am J Gastroenterol 2003;98(9):S205.
  9. Attila T, Saeian KS, Knox JF, Emmons JE, Calabrese L, Rose D, Prajapati DN, Kugathasan S, Otterson MF, Binion DG. Correlation of Short inflammatory bowel disease questionnaire with clinical status in routine management of Crohn’s disease patients including ostemates. Gastroenterology 2003;124(4) Supplement A199.
  10. Nole M, Prajapati DN. Successful treatment of Hepatocellular carcinoma in a patient with Hepatitis C without cirrhosis. Am J Gastroenterol 2006;101(9):S225.